Therapeutic Action
Progestogen
PDF page 207
Loading InternPractice…
Drug reference
Progestogen
PDF page 207
Abnormal uterine bleeding (especially functional uterine bleeding unrelated to pregnancy)
PDF page 207
Do not administer to patients with breast cancer, severe hypertension (≥ 160/100), active thromboembolic disorders, uncontrolled or complicated diabetes, severe or recent hepatic disease. May cause: menstrual irregularities, amenorrhoea, menometrorrhagia, breast tenderness, headache, weight gain, acne, mood change, abdominal pain, gastrointestinal disturbances. Pregnancy: CONTRA-INDICATED Breast-feeding: no contra-indication
PDF page 207
10 mg tablet
PDF page 207
Persistent abnormal uterine bleeding despite tranexamic acid therapy or heavy bleeding when tranexamic acid is contra-indicated Adolescent and adult: 20 mg 3 times daily for 7 days Long-term treatment of functional uterine bleeding Adult: 10 mg once daily (up to 30 mg once daily if necessary). Continue treatment according to clinical response.
PDF page 207
Unlike injectable medroxyprogesterone, the oral form has no contraceptive effect.
PDF page 207
– Below 25 °C
PDF pages 207, 208
20 mg 3 times daily for 7 days
PDF page 207
10 mg once daily (up to 30 mg once daily if necessary). Continue treatment according to clinical response.
PDF page 207